Thoma Bravo Eyes $7 Billion Sale for Healthcare Cybersecurity Firm Imprivata
According to Reuters, Thoma Bravo is working with bankers on a sale for Imprivata, which it bought for $544 million in 2016. The company now generates about $500 million in revenue and is a leader in securing healthcare data access.














































